Health
Study shows mRNA-1273 vaccine can prevent symptomatic COVID-19 infection – News-Medical.Net
A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine…
A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc.
Results from the primary analysis of the study, which will continue for two years, provide evidence that the vaccine can prevent symptomatic infection.
Among the more than 30,000 participants randomized to receive the vaccine or a placebo, 11 of those in the vaccine group developed…
-
General16 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General16 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
General16 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News20 hours agoBrisbane rising on global rankings, but still behind southern capitals